Similarly, Danti et al. confirmed that NR5A1 activation in a human embryonic stem cell (hESC) system could direct bipotential gonadal-like cells toward a steroidogenic fate, supporting the therapeutic potential of targeted NR5A1 regulation in DSD (Danti et al., 2023). Here, NR5A1 is linked to disorder of sexual differentiation.